PMC:7324763 / 44706-44823 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T333","span":{"begin":72,"end":79},"obj":"Disease"}],"attributes":[{"id":"A333","pred":"mondo_id","subj":"T333","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Tocilizumab (vs. Anakinra) NCT04339712 II Greece (17) 20 Pneumatic COVID19+, non-ICU Anakinra - IL1r antagonist"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T241","span":{"begin":41,"end":43},"obj":"Chemical"},{"id":"T242","span":{"begin":107,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A241","pred":"chebi_id","subj":"T241","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A242","pred":"chebi_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"}],"text":"Tocilizumab (vs. Anakinra) NCT04339712 II Greece (17) 20 Pneumatic COVID19+, non-ICU Anakinra - IL1r antagonist"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1328","span":{"begin":102,"end":106},"obj":"Gene"},{"id":"1361","span":{"begin":72,"end":80},"obj":"Disease"}],"attributes":[{"id":"A1328","pred":"tao:has_database_id","subj":"1328","obj":"Gene:3554"},{"id":"A1361","pred":"tao:has_database_id","subj":"1361","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab (vs. Anakinra) NCT04339712 II Greece (17) 20 Pneumatic COVID19+, non-ICU Anakinra - IL1r antagonist"}

{"project":"LitCovid-sentences","denotations":[{"id":"T274","span":{"begin":0,"end":117},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab (vs. Anakinra) NCT04339712 II Greece (17) 20 Pneumatic COVID19+, non-ICU Anakinra - IL1r antagonist"}